ScinoPharm Taiwan Ltd. | Ownership
Companies that own ScinoPharm Taiwan Ltd.
The Vanguard Group, Inc.
8,447,772
1.07%
0
0%
07/31/2018
Norges Bank Investment Management
3,927,849
0.5%
554,546
0%
12/31/2017
BlackRock Fund Advisors
2,489,735
0.32%
0
0%
09/05/2018
Dimensional Fund Advisors LP
1,109,075
0.14%
-585,456
0%
04/30/2018
BlackRock Advisors (UK) Ltd.
939,324
0.12%
0
0%
09/05/2018
SSgA Funds Management, Inc.
499,500
0.06%
0
0%
09/06/2018
Capital Investment Trust Corp.
301,633
0.04%
301,633
0.02%
03/31/2018
Parametric Portfolio Associates LLC
255,343
0.03%
0
0%
06/30/2018
TIAA-CREF Investment Management LLC
144,960
0.02%
0
0%
03/31/2018
Northern Trust Investments, Inc.
31,000
0%
0
0%
09/07/2018
| Address |
No. 1 Nan-Ke 8th Road
Tainan TQ 741 44
Taiwan
|
|
Employees
|
- |
| Website |
http://www.scinopharm.com.tw |
| Updated |
07/08/2019 |
| ScinoPharm Taiwan Ltd. engages in the manufacture and sale of pharmaceutical raw materials. It offers drug development technology, chemical process development, analytical chemistry, and manufacturing services. The company was founded November 11, 1997 and is headquartered in Tainan, Taiwan. |
